Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 298 entries
View as:

Augmentation of the Graft vs. Leukemia Effect Via Checkpoint Blockade With Pembrolizumab

Phase: N/A Priority: Normal
NCT ID: NCT03286114 Org: User:
Start: 12/21/17 End: 04/28/21 Due: 04/28/22

CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06915168 Org: User:
Start: 11/13/24 End: 01/31/26 Due: 01/31/27

Feasibility of Expressive Writing for Body Image Distress and Anxiety Among Adolescent and Young Adult Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06046014 Org: User:
Start: 09/14/24 End: 06/01/25 Due: 06/01/26

Trial of Cabozantinib (XL184) in Castrate-Resistant Prostate Cancer Metastatic to Bone

Phase: N/A Priority: Normal
NCT ID: NCT01428219 Org: User:
Start: 02/29/12 End: 09/30/15 Due: 09/30/16

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

Phase: N/A Priority: Normal
NCT ID: NCT06866262 Org: User:
Start: 07/01/25 End: 07/01/31 Due: 07/01/32

Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT00480857 Org: User:
Start: 03/31/07 End: 07/31/14 Due: 07/31/15

A Pilot Study of Roadmap 2.0 in Oncology Caregivers and Patients

Phase: N/A Priority: Normal
NCT ID: NCT04480541 Org: User:
Start: 09/18/20 End: 06/20/23 Due: 06/20/24

Reduced-intensity Therapy for Oropharyngeal Cancer in Non-smoking HPV-16 Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT01663259 Org: User:
Start: 01/31/11 End: 09/30/19 Due: 09/30/20

Bortezomib in Combination With Ibrutinib in Ibrutinib Relapsed Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03617484 Org: User:
Start: 07/31/20 End: 07/31/30 Due: 07/31/31

A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00399321 Org: User:
Start: 04/30/06 End: 09/30/10 Due: 09/30/11

A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01663272 Org: User:
Start: 07/31/12 End: 03/01/17 Due: 03/01/18

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT06941324 Org: User:
Start: 09/01/25 End: 03/01/27 Due: 03/01/28

Developing a Psychosexual Educational Partners Program: PEPP A Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT05070299 Org: User:
Start: 03/15/22 End: 08/29/22 Due: 08/29/23

Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain

Phase: N/A Priority: Normal
NCT ID: NCT01028352 Org: User:
Start: 10/31/08 End: 10/31/11 Due: 10/31/12

Altering Lipids for Tolerance of Aromatase Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04268134 Org: User:
Start: 07/28/20 End: 02/27/24 Due: 02/27/25

Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)

Phase: N/A Priority: Normal
NCT ID: NCT00141739 Org: User:
Start: 08/31/04 End: 09/30/12 Due: 09/30/13

Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01389076 Org: User:
Start: 07/31/11 End: 06/30/16 Due: 06/30/17

A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion

Phase: N/A Priority: Normal
NCT ID: NCT01210027 Org: User:
Start: 03/31/07 End: 04/01/23 Due: 04/01/24

Dose Escalation Study to Determine the Maximum Tolerated Dose of the Combination of Ruxolitinib and Bortezomib in Patients With Relapsed or Refractory Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02613598 Org: User:
Start: 05/12/16 End: 06/07/21 Due: 06/07/22

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00176761 Org: User:
Start: 03/31/00 End: 05/31/06 Due: 05/31/07

UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00146042 Org: User:
Start: 03/31/99 End: 03/31/05 Due: 03/31/06

Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer: Concordance Study

Phase: N/A Priority: Normal
NCT ID: NCT00858585 Org: User:
Start: 03/31/09 End: 09/30/16 Due: 09/30/17

Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers

Phase: N/A Priority: Normal
NCT ID: NCT00141765 Org: User:
Start: 01/31/97 End: 02/28/10 Due: 02/28/11

Trial of Pevonedistat Plus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03228186 Org: User:
Start: 03/05/18 End: 11/04/21 Due: 11/04/22

Trial of Devimistat in Combination With Modified FOLFIRINOX in Patients With Metastatic Adenocarcinoma of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT05926206 Org: User:
Start: 07/31/23 End: 01/31/27 Due: 01/31/28